Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Hartmann, Ann-Kathrin; Bartneck, Joschka; Pielenhofer, Jonas et al.

Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection

FRONTIERS IN IMMUNOLOGY. Bd. 14. 2023


Musoro, Jammbe Z.; Coens, Corneel; Sprangers, Mirjam A. G. et al.

Original Research Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types

EUROPEAN JOURNAL OF CANCER. Bd. 188. 2023 S. 171-182


Schubert, Maria-Luisa; Bethge, Wolfgang A.; Ayuk, Francis A. et al.

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study

BLOOD ADVANCES. Bd. 7. H. 20. 2023 S. 6191-6195



Sonneveld, Pieter; Chanan-Khan, Asher; Weisel, Katja et al.

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial

JOURNAL OF CLINICAL ONCOLOGY. Bd. 41. H. 8. 2023 S. 1600-+


Kaufmann, Justus; Wollschlaeger, Daniel; Nikolaidou, Eirini et al.

Pain response to postoperative spinal radiotherapy. Manifestations of multiple myeloma as a predictor of overall survival

STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. 2023 S. S163-S164


Bostel, Tilman; Wollschlaeger, Daniel; Nikolaidou, Eirini et al.

Palliative Effects and Complications after Radiotherapy of spinal Bone Lesions in elderly Patients with Multiple Myeloma

STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. 2023 S. S163-S163


Schmalfeldt, Barbara; Schmidberger, Heinz

Paradigm shift in endometrial cancer

ONKOLOGIE. Bd. 29. H. 5. 2023 S. 386-387


Kreipe, Hans; Schmidt, M

Pathologie, Prognose und Prädiktion

Untch, Harbeck, Thomssen, Lüftner (Hrsg). Colloquium Senologie. München: Lukon 2023


Singer, Susanne; Bergelt, Corinna; Tribius, Silke et al.

Patient-reported outcomes in head and neck cancer treatment: relevance, challenges, and benefit

HNO. 2023